Basic Research
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jan 28, 2008; 14(4): 554-562
Published online Jan 28, 2008. doi: 10.3748/wjg.14.554
Figure 3
Figure 3 Expression differences of biomarker proteins caused by ERK pathway activation. Cells were transfected with WT-cagA or blank vectors with treatment of MEK inhibitor U0126, or its vehicle DMSO. Expression differences of three biomarkers with m/z 4229 (CM10), 8162 (CM10) and 9084 (SAX2) between WT-cagA transfectants and vector transfectants appeared under both MEK-inhibitor-free and DMSO-treated conditions, but disappeared under inhibitor-treated conditions.